Fresh Perspectives on the CARES Trial and the Use of Febuxostat in an Asian Population: Comment on the Article by Choi et al

Arthritis Rheumatol. 2019 Mar;71(3):479-481. doi: 10.1002/art.40741.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Allopurinol
  • Febuxostat
  • Gout Suppressants
  • Gout*
  • Humans
  • Rheumatology*
  • United States Food and Drug Administration

Substances

  • Gout Suppressants
  • Febuxostat
  • Allopurinol